Tecentriq 1200 mg Injection
4.495,98$
3.978,83$
Tecentriq 1200 mg injection is a targeted immunotherapy option used in the treatment of various cancers, including lung, bladder, breast, and liver cancers. This powerful medication contains atezolizumab, which functions by inhibiting the PD-L1 protein found on certain cancer cells, a mechanism that helps these cells evade detection by the immune system. By blocking PD-L1, Tecentriq empowers the body's immune response to recognize and destroy cancer cells, potentially slowing or halting tumor growth. While effective, it’s important to note that Tecentriq may cause immune-related side effects, and patients should be monitored for signs of inflammation in various organs. As a prescription medication, it should only be administered under the supervision of a healthcare professional who can assess the benefits and risks involved. Patients receiving Tecentriq should discuss their complete medical history and any ongoing medications to ensure a safe treatment plan. With its innovative approach to cancer therapy, Tecentriq represents a promising advancement in the fight against various malignancies, offering hope for improved outcomes.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Tecentriq 1200 mg injection is utilized in the treatment of early-stage non-small cell lung cancer (NSCLC) for patients who have had surgery and completed platinum-based chemotherapy. This medication is recommended as an adjuvant therapy for those whose tumors express PD-L1 on at least 1% of tumor cells. By inhibiting the PD-L1 protein, Tecentriq 1200 mg injection helps to activate the immune system. This immune response can potentially reduce the risk of cancer recurrence or progression.
• In cases of metastatic non-small cell lung cancer, Tecentriq 1200 mg injection is administered in combination with other agents like bevacizumab, paclitaxel, and carboplatin. This regimen is indicated as a first-line treatment for patients with metastatic non-squamous NSCLC. The role of Tecentriq in this context is to enhance the body’s immune response against cancer cells. This can lead to improved outcomes for patients facing advanced stages of this disease.
• Tecentriq 1200 mg injection is also indicated for the treatment of extensive-stage small cell lung cancer when used alongside carboplatin and etoposide. This combination therapy is designed to provide an effective first-line treatment option for patients. By leveraging the immune-modulating properties of Tecentriq, the treatment aims to combat the aggressive nature of small cell lung cancer. This approach may help in managing disease progression in affected individuals.
• For patients with urothelial carcinoma, Tecentriq 1200 mg injection serves as a therapeutic option targeting transitional cell carcinoma, which affects the urinary tract. This medication can alleviate symptoms and is a crucial part of the treatment landscape for this type of cancer. By enhancing the immune response, Tecentriq aims to control tumor growth and improve patient outcomes. Its use is essential for individuals diagnosed with this challenging condition.
Benefits
Tecentriq 1200 mg Injection is an immunotherapy drug that activates the body's immune system to fight cancer cells. It is used to treat various types of cancer, including lung cancer, bladder cancer, triple-negative breast cancer, and liver cancer. Tecentriq 1200 mg Vial has been shown to improve overall immunity and survival in advanced-stage non-small cell lung cancer, triple-negative breast cancer, and bladder cancer. Compared to other anticancer medicines, Tecentriq Injection is associated with very few side effects. It is important to note that the specific benefits of Tecentriq 1200 mg Injection may vary depending on the type and stage of the cancer being treated, as well as the individual patient's overall health and medical history. Therefore, it is essential to discuss the potential benefits and risks of Tecentriq 1200 mg with a doctor before starting treatment.
Side Effects
Like all medications, Tecentriq 1200 mg Vial can cause side effects, but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Constipation
• Breathlessness
• Decreased Appetite
• Coughing
Common Side Effects
• Black and Tarry Stools
• Fever
• Pain in Bladder
• Breathing Difficulty
• Diarrhoea
• Hair Loss
How To Use
Tecentriq 1200 mg Injection is an intravenous infusion, Administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of the Atezolizumab Injection 1200 mg will be determined by the patient's clinical condition, age, medical history, type of cancer and other factors. It is important to note that this Tecentriq 1200 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Anti-cancer Drug Tecentriq.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Tecentriq 1200 mg Vial. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Tecentriq 1200 mg Vial should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Tecentriq 1200 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Tecentriq 1200 mg Injection may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Tecentriq 1200 mg Vial. Tecentriq 1200 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Tecentriq 1200 mg Injection, it is essential to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor can help you make the best decision for you and your baby's health.
• Liver: Anti-cancer Drug Tecentriq should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Tecentriq 1200 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Atezolizumab Injection 1200 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Tecentriq Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Tecentriq 1200 mg during pregnancy. Your doctor can help you make the best decision for you and your baby's health.
• Driving: Tecentriq 1200 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Tecentriq 1200 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.